Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T18:02:50.370Z Has data issue: false hasContentIssue false

Experience with Thioridazine (“Melleril”) Therapy

Published online by Cambridge University Press:  08 February 2018

N. Gold*
Affiliation:
Park Prewett Hospital, Basingstoke
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

“A doctor must know not only the virtue of a drug, but also its drawbacks”—

Carling (1960).

Thioridazine is one of the newer phenothiazine derivatives used in psychiatry. Previous workers have reported few serious side-effects with it. The following pilot trial was carried out on male patients suffering from chronic schizophrenia who required nursing in a closed ward.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 
Submit a response

eLetters

No eLetters have been published for this article.